The importance of B cells in MS onset and their involvement in OCBs production is reinforced by studies reporting increased levels of CXCL13, a strong chemoattractant for B cells produced by APCs [125], in the CSF of MS patients [126]. Here, CXCL13 is linked to myeloid sarcoma.